Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
$1.48−0.08 (-5.13%)
Close on Nov 17, 2026Market cap $526.23MP/E –Yield –
Evotec operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -€9.18M, down 150.4% from the year before. The highest annual figure on record is €205.81M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€9.18M | -150.4% |
| FY2024 | Dec 31, 2024 | €18.22M | -50.0% |
| FY2023 | Dec 31, 2023 | €36.44M | -82.3% |
| FY2022 | Dec 31, 2022 | €205.81M | +62.6% |
| FY2021 | Dec 31, 2021 | €126.60M | +183.1% |
| FY2020 | Dec 31, 2020 | €44.72M | +5.9% |
| FY2019 | Dec 31, 2019 | €42.22M | – |
See a number that looks wrong?